Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015

BACKGROUND: Artemisinin-based combination therapy is the first-line anti-malarial treatment for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of polymorphisms in the pfk13 gene, associated with artemisinin resistance, and pfmdr1, associated with lumefantrine resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljolje, Dragan, Dimbu, Pedro Rafael, Kelley, Julia, Goldman, Ira, Nace, Douglas, Macaia, Aleixo, Halsey, Eric S., Ringwald, Pascal, Fortes, Filomeno, Udhayakumar, Venkatachalam, Talundzic, Eldin, Lucchi, Naomi W., Plucinski, Mateusz M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819161/
https://www.ncbi.nlm.nih.gov/pubmed/29458380
http://dx.doi.org/10.1186/s12936-018-2233-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819161/
https://www.ncbi.nlm.nih.gov/pubmed/29458380
http://dx.doi.org/10.1186/s12936-018-2233-5

Ejemplares similares